- Home
- CASI vs LNSR Comparison
CASI vs LNSR Comparison
Compare CASI & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- LNSR
- Stock Information
- Founded
- CASI 1991
- LNSR 2004
- Country
- CASI China
- LNSR United States
- Employees
- CASI N/A
- LNSR N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- LNSR Medical Electronics
- Sector
- CASI Health Care
- LNSR Health Care
- Exchange
- CASI Nasdaq
- LNSR Nasdaq
- Market Cap
- CASI 58.8M
- LNSR 63.4M
- IPO Year
- CASI 1996
- LNSR N/A
- Fundamental
- Price
- CASI $2.99
- LNSR $8.68
- Analyst Decision
- CASI Strong Buy
- LNSR
- Analyst Count
- CASI 1
- LNSR 0
- Target Price
- CASI $6.00
- LNSR N/A
- AVG Volume (30 Days)
- CASI 56.2K
- LNSR 47.0K
- Earning Date
- CASI 11-15-2024
- LNSR 11-07-2024
- Dividend Yield
- CASI N/A
- LNSR N/A
- EPS Growth
- CASI N/A
- LNSR N/A
- EPS
- CASI N/A
- LNSR N/A
- Revenue
- CASI $22,055,000.00
- LNSR $48,868,000.00
- Revenue This Year
- CASI N/A
- LNSR $25.07
- Revenue Next Year
- CASI $134.79
- LNSR $24.95
- P/E Ratio
- CASI N/A
- LNSR N/A
- Revenue Growth
- CASI N/A
- LNSR 21.29
- 52 Week Low
- CASI $2.05
- LNSR $2.67
- 52 Week High
- CASI $8.19
- LNSR $9.23
- Technical
- Relative Strength Index (RSI)
- CASI 39.36
- LNSR 62.59
- Support Level
- CASI $2.50
- LNSR $7.33
- Resistance Level
- CASI $3.47
- LNSR $9.23
- Average True Range (ATR)
- CASI 0.47
- LNSR 0.64
- MACD
- CASI 0.05
- LNSR 0.04
- Stochastic Oscillator
- CASI 38.78
- LNSR 59.05
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.